In a number of human diseases, including depression, interactions between genetic and environmental factors have been identified in the absence of direct genotype-disorder associations. The lack of genes with major direct pathogenic effect suggests that genotype-specific vulnerabilities are balanced by adaptive advantages and implies aetiological heterogeneity. A model of depression is proposed that incorporates the interacting genetic and environmental factors over the life course and provides an explanatory framework for the heterogeneous aetiology of depression. Early environmental influences act on the genome to shape the adaptability to environmental changes in later life. The possibility is explored that genotype-and epigenotype-related traits can be harnessed to develop personalized therapeutic interventions. As diagnosis of depression alone is a weak predictor of response to specific treatments, aetiological subtypes can be used to inform the choice between treatments. As a specific application of this notion, a hypothesis is proposed regarding relative responsiveness of aetiological subtypes of depression to psychological treatment and antidepressant medication. Other testable predictions are likely to emerge from the general framework of interacting genetic, epigenetic and environmental mechanisms in depression.
Gene-environment interactions
Recent advances in neuroscience demonstrate that genetic and environmental factors do not act in isolation. Effects of environmental factors depend on the genetic background and any impact of genetic variation on behaviour is contextualized by environment. Such findings are causing a paradigm shift from single-factor-deterministic to a multi-factor-contextual perspective. This new perspective is proving fruitful in the aetiological research on psychiatric disorders. Gene-environment interactions (G Â E) have been found in the aetiology of a number of physical and mental diseases. [1] [2] [3] [4] [5] These interactive relationships are proving to be more replicable than direct gene-disorder association. 6, 7 However, the emerging knowledge of interacting genetic and environmental causes of diseases has not yet been translated into clinical applications. In the following paragraphs, I will review the aetiology of depression, explore the principles of G Â E and propose a framework that can be applied to inform treatment.
The interacting causes of depression
Social and genetic factors are established as component causes of depressive illness, but lack general explanatory power when considered in isolation. Early experiences of parental care or neglect have a lasting influence on the onset and perpetuation of depressive illness in adulthood, which is partially mediated by proximal social factors, including quality of core intimate relationship and stressful life events. 8 Considered together, early and proximal social factors explain a large proportion of depression in population-based samples. 8 However, these social factors account for relatively smaller proportion of depression in clinically ascertained samples 9, 10 and fail to explain the grater differences in risk of depression between monozygotic compared to dizygotic twins. 11, 12 The evidence for genetic influences on depression consists primarily of twin studies. The higher depression concordance rates in monozygotic than in dizygotic twins are replicable, but the degree of genetic contribution gives a mirror image of the social studies: it is larger in clinically ascertained than in community-based samples. 11, 12 These discrepancies may be due to G Â E, as in twin studies, any interaction between genes and shared environmental factors is allocated to the additive effect of genes. 13 The twin resemblance in vulnerability to the depression-inducing effects of stressful life events also indicates that G Â Es account for a significant proportion of twin concordance. 14 A specific G Â E between a common functional length polymorphism in the serotonin transporter gene (5-HTTLPR) and stressful life events has been identified. In a large cohort, childhood abuse and stressful life events were associated with high risk of becoming depressed in individuals with 5-HTTLPR 'short' alleles, but had little effect on depression among 'long' allele homozygotes. 3 These results are supported by animal research and replicated in most human studies. 7 Two aspects of these findings are of relevance here. First, depression does not appear to be more common among 5-HTTLPR short allele carriers. 15 Second, carriers of 5-HTTLPR short alleles derive more benefit from positive aspects of the environment, such as social support. 16, 17 These results suggest that 5-HTTLPR short alleles render an individual sensitive to both positive and negative experiences. At a population level, protective effects of positive experiences balance the depressogenic effect of adversity, resulting in no net genotypedepression association. Individuals with 5-HTTLPR long alleles get depressed just as often, but for reasons relatively independent of environmental stress. This aetiological heterogeneity remains to be exploited to inform the therapeutics of depression.
Although G Â Es involving the 5-HTTLPR have been explored in greatest detail, this gene is unlikely to act in isolation. Polymorphisms in at least two other functional candidate genes have been shown to enter into similar interactions with environmental factors. A single nucleotide polymorphism in the gene encoding brain-derived neurotrophic factor (BDNF) has been shown to interact with the 5-HTTLPR on molecular and system level 18 and to further strengthen the G Â E between 5-HTTLPR and environmental adversity in epidemiological studies. 16, 19, 20 Specifically, human epidemiological studies indicate that BDNF 66met allele interacts with the 5-HTTLPR short allele to confer sensitivity to positive and negative environmental factors. This three-way interaction may be especially relevant to the treatment of depression as BDNF has been shown to mediate the effects of antidepressants, including those acting on the serotonin transporter. [21] [22] [23] As dysregulation of the hypothalamic-pituitaryadrenal axis (HPA) is associated with both early adverse experiences and with depression, 24, 25 it comes as no surprise that the gene coding for the corticotrophin releasing hormone receptor (CRHR1) also appears to interact with child abuse in the genesis of adult depression. 26 Although this latter finding awaits replication and integration with the knowledge on 5-HTTLPR and BDNF, it supports the notion that the G Â E may provide a general framework for the aetiology of depression. Like 5-HTTLPR, neither BDNF nor CRHR1 genes are directly associated with depression. Thus, it appears that polymorphisms in several genes may combine to produce environmentally sensitive or insensitive dispositions without directly increasing the risk of depression.
Principles of gene-environment interactions
Principle I: degeneracy of biological systems A number of experiments in simple and complex organisms have shown that change in a single genetic or environmental factor often has little or no appreciable effect on behaviour. Deletions of single genes with apparently significant functions often have no observable effects in laboratory animals and humans can live without the most common blood protein (albumin) or the largest fibre tract in the brain (corpus callosum) with little or no adverse consequence. 27 This remarkable adaptability is due to degeneracy: the fact that biological functions can be performed by multiple structurally distinct mechanisms. 27, 28 Degeneracy is a ubiquitous property of biological systems that has been upheld through natural selection, as it allows adaptation to unpredictable changes in environment. 27 In a degenerate system, any perturbation is balanced by adaptive changes in other components, minimizing the impact of any single change. 28 Importantly, the effect of single gene variation can become manifest under constrained environments, resulting into intriguing differences between laboratory and natural environment or even between different laboratories. 29 An extension of the degeneracy principle to the causation of human disease has two major implications. First, an individual case of disease is likely to be the result of multiple contributing causal factors. Second, cases of the same disease in human population are likely to be due to multiple causal mechanisms. 30 In other words, a disease is likely to be a common result of multiple causal pathways, and each causal pathway is likely to comprise multiple causative factors.
Indeed, multiple factors have to co-occur to cause depression. Although stressful life events are among the strongest predictors of depression onset, the occurrence of a severe stressful life event has little effect in the absence of pre-existing vulnerability. 8 Similarly, tryptophan depletion leads to depressed mood only in predisposed individuals 31 and no single genetic polymorphism causes depression. 12, 32 The causes of depression are likely to differ between individuals. Aetiological heterogeneity is apparent in the discrepant heritability estimates from clinical and population-based samples, 11, 12 and from the different contributions of stressful life events to episodes of neurotic and melancholic depression. 9 As will be discussed below, aetiological heterogeneity is also implicit it the pattern of findings emerging from studies of G Â E.
Principle II: gene-environment interactions and aetiological heterogeneity Many G Â E identified in the aetiology of physical and mental diseases are not accompanied by a direct association between disease and genotype. 3, 5, 33 These interactions without main genetic effect indicate aetiological heterogeneity with another environmental factor balancing the influence of the identified exposure. Crossed G Â E interactions without a firstorder effect of genotype may appear contraintuitive and are inconsistent with the traditional vulnerability-stress model of illness, but their existence is a direct implication of the evolutionary theory. Genetic polymorphisms involved in such interactions may have been maintained through evolution as differential advantages of individuals under varied circumstances promoted survival. 34, 35 It follows that at individual level, vulnerability factors are offset by a latent advantage to adapt to different circumstances. Therefore, G Â E without a main effect of genotype indicate an opportunity for individualized therapeutic and preventative interventions that capitalize on the adaptive potential of genotypes in various environments.
Principle III: the importance of early environment Early in individual development, there appears to be a window of genomic plasticity, during which the expression of specific genes may be conditioned in a tissue-specific manner. 25, 36, 37 It has been proposed that this developmental programming has an adaptive function in preparing an individual for a life under environmental conditions predicted on the basis of early experiences. 38 Thus, as adverse early environment is likely to predict later adversity, the genetic expression is tuned up into a high-risk high-resilience program. This programming is maintained throughout life by relatively stable epigenetic modifications of the DNA and chromatin. 39 The vulnerability to depressogenic effects of environmental insults also appears to be stable over time and to be determined by genetic and early environmental factors. It has been pointed out that the G Â Es in the aetiology of depression most consistently involve early environmental factors such as parenting, neglect and abuse in childhood. 40 Given the strong influence of such early factors on onset and perpetuation of depression in adulthood, a model of depression must include a mechanism of this longterm memory.
It has been demonstrated that any long-term memory depends on changes in gene expression, maintained by transcriptional factors and epigenetic mechanisms including chromatin modifications and DNA methylation. 41 These various mechanisms of memory operate on different timescales: transcriptional factors can be activated within minutes to hours, histone modifications are induced by experiences lasting several days to weeks and DNAmethylation is the most long-lasting mechanism. 41 DNA-methylation has been shown to persist from early developmental stages into adulthood 25 and thus is the most likely candidate mechanism for persistent memory trace between childhood experiences and adult depression. Epigenetic modifications resulting from adverse childhood experiences are likely to modify through the life course the expression and inducibility by stress of key proteins in the hypothalamus-pituitaryadrenal axis, 24, 25 neurotrophins, 42 immune system 43 and serotonergic neurotransmission, 44, 45 and thus shape the vulnerability to depression.
Beneath the surface: molecular mechanisms
Three alternative hypotheses can be presented as to where and when the G Â E occurs. The first possibility is that the polymorphic gene entering into G Â E is itself epigenetically modified as a result of early adverse experience. It is conceivable that polymorphisms in DNA sequence can alter the availability of cytosine-phosphate-guanine sites for methylation, but to date, differential methylation of genes entering into G Â E has not been demonstrated. A second possibility is a double-hit mechanism, where one gene (for example, the glucocorticoid receptor gene) is epigenetically modified as a result of early adverse experience and the impact of this modification in adult life is moderated by sequence polymorphism in another functionally related gene (for example, serotonin transporter). Again, specific evidence for this mechanism is lacking. A third alternative is that a DNA sequence polymorphism (for example, in the serotonin transporter gene) moderates the effects of early environment on the programming of other functionally related genes. This third mechanism has most empirical support, at least for the serotonin transporter. The lack of functional serotonin transporter at early developmental stages leads to a lifelong phenotype of anxiety-like and depression-like behaviours in novel environments. 44, 46, 47 This lasting effect is mediated by increased extracellular serotonin during the plastic early developmental period and subsequent downregulation and desensitization of the inhibitory 5-HT1A receptors. 46 A less pronounced reduction in the serotonin reuptake due to presence of 5-HTTLPR low expressing alleles may lead to similar consequences only in the presence of increased serotonin efflux, due to stress in the early developmental period. The co-occurrence of stressful environment with weak serotonin reuptake in early life (a G Â E) results in programming of genes in the serotonergic and stress response systems that is associated with increased anxiety and decreased adaptability to change in later life. This programming is likely to involve signalling through serotonin receptors. Some of this programming is brain-region specific, but overall the presynaptic 5-HT1A/B and postsynaptic 2-HT2A/C signals are downregulated. 48, 49 This programming results in little or no differences in extracellular serotonin and serotonin reuptake capacity in the absence of stress 50 but can be detected through changed expression of serotonergic 5-HT1A receptors 51 and in adaptation to stress. 7 The mechanism of this programming has not yet been mapped out, but it likely involves methylation of the promoters of the 5-HT receptors and components of the signal transduction.
DNA methylation is relatively stable and unlikely to be substantially modified in adult life other than by means of pharmacological manipulation targeting the chromatin. 25 Repeated doses of antidepressant medication have been shown to modify histone acetylation, 23 but there is no evidence that currently available antidepressants affect DNA methylation. The fact that the protective effect of antidepressants ceases when the medication is discontinued indicates that long-standing dispositions are not modified by antidepressant treatment. Therefore, I will consider how treatments may act on the background of these long-term dispositions rather than treatments reversing the developmental programming.
Let's now consider the role of serotonin and the 5-HTTLPR in depression. Stress (a trigger of depression) and serotonin reuptake inhibitors (therapeutic agents) both increase the availability of serotonin in target brain regions. 52, 53 Serotonin reuptake inhibitors and tianeptine have opposite effects on serotonin reuptake but similar antidepressant efficacy. 54 These apparent paradoxes suggest that depression cannot be simply explained as a deficit or excess of serotonin. It is more likely that the function of serotonin in organism's adaptation to environmental changes can be disturbed in more than one way reflecting aetiological heterogeneity of depression.
The 5-HTTLPR is located in the regulatory region of the serotonin transporter gene: it does not alter the transporter protein but influences the regulation of its production. 7 The 5-HTTLPR short allele is consistently associated with lower expression in vitro, 55, 56 but does not appear to influence the availability of serotonin transporter in mature organisms at resting condition. 7, 50 The most parsimonious explanation, consistent with the degeneracy principle, is that the inborn potential for lower expression is balanced by developmental changes in other components of the serotonergic system. 57, 58 The lower potential for expression is however likely to be manifest at early developmental stages and under conditions of heightened demand, such as during severe stress. 7, 58 When environmental stressors trigger serotonin release, the more efficient 5-HTTLPR long alleles may upregulate the serotonin transporter production to balance the serotonin levels and moderate the impact on target brain structures. The short alleles are less efficient and may leave their carriers more exposed to the effects of environmental stressors. These genetic differences are expressed since early stages of development. If the developing brain is exposed to excess of serotonin during a plastic early period, epigenetic programming may induce changes that are designed to balance such effects in later life. 38, 44, 59 These changes are likely to include desensitization of serotonin receptors to reduce the impact of excessive serotonin. 51, 60 Specifically, functionality of the 5-HT1A receptors is decreased in animals and humans with genetically decreased serotonin transporter function. 48, 51 Without the balancing effect of the efficient 5-HTTLPR long allele, this programming increases stress-sensitivity and anxiety in response to novelty in adult life. 7, 44, 47 This programming may have an adaptive function: if early stress predicts dangerous conditions in later life, it may be advantageous to enhance self-protective functions at the expense of exploratory behaviour.
In adulthood, serotonin mediates the depressogenic effects of stress. Limiting the serotonin surge in response to repeated stress abolishes the depressogenic effect of the stressor. 52 The combination of the less efficient short alleles and downregulated 5-HT1A receptors may leave their carriers exposed to the effects of environmental changes, perhaps both positive and negative ones. Prolonged stress is then associated with lasting high levels of extracellular serotonin and further downregulation of serotonergic receptors; downstream effects may include inhibition of dopaminergic neurons in the ventral tegmental area, increased activation of the HPA axis and reduction in hippocampal neurotrophins (Figure 1a) . The serotonergic inhibition of hippocampal neurotrophins 61 may be compounded and perpetuated by the less effective 66met allele of the BDNF gene, 16 methylation of the glucocorticoid receptor 25 and functional variants of the CRHR1. 26 The reversal of this dysregulation in individuals with environmentally sensitive disposition may occur through inhibition of the serotonergic efflux under favourable environmental conditions. In response to mastery experience (for example, during psychotherapy, or after fresh-start events), the ventromedial prefrontal cortex inhibits the serotonergic neurons via a glutamatergic pathway to g-amino butyric acid interneurons in the dorsal raphe, 52 thus interrupting the depressogenic cascade (dotted lines in the Figure 1a) .
Among 5-HTTLPR long allele homozygotes, environmental stress appears to be of little importance in the genesis of depression. These individuals may be relatively protected from long-lasting effects of stress by the inducible removal of serotonin through an efficient transport. However, a similar proportion of these individuals develop depression. This may also be a result of interaction between early developmental programming and later environmental conditions. It has been shown that increased expression of the serotonin transporter during development leads to life-long hypersensitivity of the 5-HT2A receptors. 62 Increased 5-HT2 signalling has been hypothesized to be involved in the pathogenesis of melancholic depression, as it reduces dopaminergic transmission and hippocampal neurotrophins. 53, 61 This can lead to a life-long latent vulnerability to depression in some long allele homozygotes which manifests in response to other conditions, such as decreased serotonergic transmission during tryptophan depletion. 63 Clearly, this vulnerability is only present in a proportion of long allele homozygotes, suggesting a modifying effect of another as yet unknown environmental or genetic factor. The effective serotonin removal Implications of G Â E in depression R Uher mechanism in 5-HTTLPR long allele carriers may decrease the level of serotonin signalling below optimum and lead to depression in a scenario consistent with the classical serotonin hypothesis of depression. 64 The rapid on and off pattern of serotonin firing and removal may lead to differential effect on the 5-HT1A and 5-HT2 receptors with a relatively stronger transmission on the hypersensitive 5-HT2 receptors. In this situation, serotonin reuptake inhibitors have the potential to redress the balance by prolonging the action of serotonin at the synapses, as is reflected in their relatively good antidepressant efficacy in long allele carriers (Figure 1b) . 65 The two scenarios involving increased and decreased levels of serotonin may both lead to the common symptoms of depression through differential modulation of neurotrophins 61 and dopaminergic transmission. 53 Accordingly, it is possible that aetiological subtypes of depression may be dissected by pharmacological means. 53 For example, blockage of the hypersensitive 5-HT2 receptors in the environmentally insensitive subtype of depression through agents like agomelatine 66 and mirtazapine 67 could result in rapid mood improvement. However each of these available drugs has several mechanisms of action and subsequently, differential efficacy in aetiologically defined subgroups is difficult to predict. The development of selective 5-HT2A blockers for use in humans may facilitate the differentiation and treatment of aetiological subtypes of depression. 53 
Clinical heterogeneity in response to treatments
Psychological therapy and antidepressant medication have, on average, comparable efficacy in unselected groups of patients diagnosed with depression, but secondary analyses indicate that distinct subgroups respond to psychological and pharmacological treatments. 68 Previous non-response to medication is a predictor of better response to psychological Figure 1 Model of gene-environment interaction in depression. (a) Environmentally sensitive depression: an environmental stressor (lower left corner) leads to an increase in serotonin signalling that is not adequately regulated due to weak serotonin reuptake modulation (thin circular arrow) and desensitized inhibitory 5-HT1A receptors (empty diamonds). The increased serotonin inhibits the dopaminergic system (leading to anhedonia) and hippocampal neurotrophins (decreasing neurogenesis). Pharmacological blockade of serotonin reuptake is relatively ineffective as serotonergic receptors are downregulated. Experience of mastery over environment (stress controllability) is detected in the prefrontal cortex, which inhibits the serotonergic raphe nuclei through GABA-ergic interneurons (dotted pathway), leading to recovery. (b) Environmentally insensitive depression: vulnerability of unknown character (that is manifest as sensitivity to tryptophan depletion; '?') interacts with an efficient serotonin reuptake mechanism (thick circular arrow) to sensitize 5-HT2A receptors (full stars), thus leading to inhibition of dopamine and neurotrophic systems. Pharmacological inhibition of the serotonin reuptake prolongs the presence of serotonin at the synapses and leads to desensitization of 5-HT2A receptors. Through downstream changes in the dopamine and neurotrophic systems, these processes relieve depressive symptoms. Abbreviations: 5-HT, serotonin; DA, dopamine; BDNF, brain-derived neurotrophic factor; GLU, glutamate; GABA, g-amino butyric acid; 5-HT2A, serotonin receptors 2A; DRN, dorsal raphe nucleus; VTA, ventral tegmental area; Nac, nucleus accumbens; SRI, serotonin reuptake inhibitors. treatment and worse response to a further trial of medication. 69 A good response to a switch between psychological treatment and medication 68 compares favourably with the more modest benefit of switching between different medications. 70 These facts point at a heterogeneity within depression that only becomes evident by trial and error exposure to various treatments.
Clinicians have long intuited that the way into depression should point to a way out of it and have searched for subtypes of depression that could inform the choice of treatment. The distinction between reactive and endogenous depression reflected this intuition. 71 The reactive subtype of depression was held to result from psychosocial causation, be comprised of neurotic symptoms and likely to improve with psychological therapy. The endogenous subtype was assumed to have biological causes, include somatic symptoms and require physical treatment. However, the distinction between reactive and endogenous depression based on symptom counts has proven to be unstable across episodes 72 and a weak predictor of differential treatment outcome. 73 However, an improved classification is possible, especially if the melancholic syndrome is defined, 74, 75 and the course of the illness is taken into account. 9 A synthesis of the genetic and social studies suggests that episodic depression may have stronger genetic component and chronic depression may have greater psychosocial contribution, especially early adversity, in its aetiology. In the light of recent knowledge on G Â E, it also appears that aetiological perspective comprising both genotype and environment may improve the predictive validity of depression classification.
Can cause inform cure?
The clinical applicability of any aetiological classification depends on the extent of overlap between the aetiological heterogeneity and the clinical heterogeneity in response to treatments. I will explore this question with regard to the distinction between antidepressant medication and psychological therapies. Although there is important variety within each of these groups of treatments, this distinction is the most prominent one.
If we accept that G Â Es reflect a general sensitivity to both positive and negative aspects of social environment, it is important to consider whether such sensitivity can extend to the effects of psychological therapy. Most psychological therapies offer tools to modify the impact of stressors and an opportunity to experience mastery over environment. It is plausible that individuals with a sensitive genotype who are vulnerable to develop depression following adverse experiences may also be more likely to benefit from mastery experiences during psychological treatment. This effect may be mediated by inhibition of the hyperactive serotonin signalling through action of the medial frontal cortex (Figure 1a) . 52 On the other hand, depressed carriers of an environmentally insensitive genotype may be more likely to require a modification of the pathological process by means of pharmacological treatment. The latter is likely to involve desensitization of the hypersensitive 2-HT2A receptors (Figure 1b) . 53, 62 I propose that the G Â E interaction characterizes an aetiological dimension of depression that is associated with differential response to antidepressant medication and psychological treatment. Specifically, individuals carrying the sensitive genotype (short 5-HTTLPR and/or 66met BDNF) who had experienced significant environmental adversity before the onset of depression will respond better to psychological treatment than to medication. Conversely, individuals carrying the environmentally insensitive genotype (long 5-HTTLPR and/or 66val BDNF) or who had not experienced significant environmental adversity will respond better to antidepressant medication.
Two lines of evidence support the above proposed hypothesis. Firstly, in a large randomized controlled trial, a history of childhood trauma predicted a better response to psychological treatment and a worse response to pharmacotherapy. 76 As childhood trauma is more likely to be involved in the development of depression in carriers of environmentally sensitive genotypes, 3, 16 5-HTTLPR short allele and BDNF 66met allele carriers are likely to have been overrepresented among depressed individuals reporting a history of childhood trauma. Consequently, the G Â E (rather than childhood trauma alone) may be the true determinant of differential response to psychological and pharmacological intervention.
Secondly, among people with depression, carriers of the 5-HTTLPR short alleles derive less benefit from antidepressant medication than carriers of long alleles, 65 suggesting that the environmentally sensitive genotype may be associated with smaller effect of pharmacological treatment.
Although these findings indirectly support the hypothesis, a formal test will require a comparison of randomly allocated psychological and pharmacological interventions to a large group of depressed individuals with genotype and history of environmental adversity assessed prior to the intervention. As it is likely that numerous genetic and environmental factors have additive and interacting effects, the G Â E contribution to the aetiology of depression should be conceptualized as a dimensional rather than categorical predictor of differential response to medication and psychological treatments.
Generalizability and caveats
The proposed model does not attempt to explain the totality of depression, but focuses on a specific causal pathway and its relationship to treatment. The G Â E between 5-HTTLPR and life events explains approximately 8% of depression cases. 3, 7 However, a larger attributable fraction is likely if several Implications of G Â E in depression R Uher synergistic genetic and environmental factors are incorporated and if the focus is on chronic and recurrent depression. 40 The aetiology of depression in individuals with environmentally insensitive genotype is less well understood. Tryptophan depletion studies indicate stable vulnerability in long allele carriers with history of depressive episodes 63 and animal models suggest mediation by hyperactive 5-HT2A receptors. 62 However, additional genetic or environmental factors are likely to interact with the environmentally insensitive genotype to produce heterogeneity of vulnerability to depression in this group. The nature of these factors is unknown. Highlighting aetiological heterogeneity may stimulate research into environmental and genetic factors that contribute to depression in this group.
Although the model and hypothesis presented above are consistent with the bulk of available evidence, there are caveats. The interaction between 5-HTTLPR and environmental adversity has been replicated in many but not all studies. Important non-replications may require specification of hypotheses for various age and gender groups and types of environmental stressors. 7, 40 Similarly, the relationship between 5-HTTLPR genotype and efficacy of serotonin reuptake inhibitors depends on population under study, suggesting moderation of 5-HTTLPR effect by other as yet unknown factors. 7, 65 Finally, the above-presented hypothesis does not specify the types of psychological and pharmacological treatments. As for psychological therapies, the opportunity to experience mastery and controllability of environment is common to most structured therapeutic approaches. Hence, the G Â E aetiological dimension is expected to similarly predict efficacy of cognitive behaviour, interpersonal or other psychotherapies. As for medication, the model focuses on serotonin reuptake inhibition as the mechanism of action. However, as most antidepressants downregulate 5-HT2 receptors, 53 generalization to other modes of action can be cautiously expected.
Conclusions and directions
The proposed model provides a framework for research with the potential of translating the G Â E concept into clinically applicable aetiological classification. Gaps in knowledge, including the pathogenesis of depression in individuals carrying environmentally insensitive genotypes, are highlighted to stimulate further research. Additional hypotheses can be presented concerning the relative effects of different pharmacological agents. For example, inhibition of the 5-HT2A receptors and augmentation with mood stabilizers may be more effective in cases of depression associated with lesser environmental sensitivity, pronounced episodic course and hypersensitive 2-HT2A receptors. Additionally, subtypes of depression can be identified which are less responsive to all available treatments.
Development of antidepressants with novel modes of action may benefit from a focus on such resistant subtypes, rather than striving for average efficacy in the heterogeneous group of patients diagnosed with major depression.
